Dapoxetine hydrochloride
SIGMA/D7071 - ≥98% (HPLC)
Synonym: (S)
CAS Number: 129938-20-1
Empirical Formula (Hill Notation): C21H23NO · HCl
Molecular Weight: 341.87
MDL Number: MFCD08272809
Linear Formula: C21H23NO · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C21H23NO.ClH/c1-22(2)2 |
| InChI key | IHWDIQRWYNMKFM-BDQAORGHSA |
| optical activity | [α]/D +125 to +135°, c = 1 in methanol |
| originator | Eli Lilly |
| Quality Level | 100 ![]() |
| SMILES string | Cl.CN(C)[C@@H](CCOc1cccc2 |
| solubility | DMSO: ≥20 mg/mL |
| storage condition | desiccated |
| storage temp. | room temp |
| Biochem/physiol Actions: | Dapoxetine is capable of blocking recombinant Kv4.3 potassium voltage-gated channels. It is considered as safe. |
| Biochem/physiol Actions: | Potent and selective SSRI |
| Biochem/physiol Actions: | Potent Selective serotonin reuptake inhibitor (SSRI); used in treatment of premature ejaculation |
| Features and Benefits: | This compound is featured on the Biogenic Amine Transporters page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Eli Lilly . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Dapoxetine ((+)-(S)-N,N-dimethyl-(α) |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H319 - H413 |
| Precautionary statements | P305 + P351 + P338 |
| Hazard Codes | Xn,N |
| Risk Statements | 22-36-50/53 |
| Safety Statements | 36-60-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


